How do you redesign a port for bigger ships and safer navigation? At #SIOP2026, Thierry Rault shares how physical models and real-time simulations shaped Genoa’s new breakwater. Discover more: https://ow.ly/j6zx50ZX7sV

Last week, we joined the global childhood cancer community at #SIOP2026 in San Antonio. 🌍

Highlights included connecting with the Rylan Strong Network, meeting SIOP President Prof Rob Pieters and hosting our session with Amgen on trusted international collaboration.

#ChildhoodCancer

At #SIOP2026, Caitlyn Duffy, MD, MPH, shared how the ARIA Guide is helping expand access to evidence-based childhood cancer care worldwide.

Developed through worldwide collaboration, ARIA provides resource-stratified clinical guidance designed for a wide range of care settings. Learn more:

We’re on the ground at #SIOP2026, where we’ll support new data from an IST in Japan, a product theater and an independent #CME sponsored by our partner, Norgine. #PediatricOncology

What can we learn from children whose hepatoblastoma progresses or returns? At #SIOP2026, Allison O’Neill, MD, shares findings from the international RELIVE registry examining the presentation and outcomes of progressive and relapsed hepatoblastoma.

PROTACs and molecular glues are opening new ways to target proteins that have historically been difficult to reach with conventional drugs. At #SIOP2026, Scott Armstrong, MD, PhD, explores the potential of these emerging approaches in pediatric cancer.

How can we continue to improve care for children with metastatic Wilms tumor? At #SIOP2026, Elizabeth Mullen, MD, FAAP, joins the IPSO/PROS/SIOP metastatic Wilms tumor session to discuss the latest thinking in pediatric oncology.

Surviving childhood cancer can bring challenges that extend long beyond treatment.
At #SIOP2026, Joan Hanania, PhD, joins a panel exploring the experiences and needs of adolescent and young adult survivors as they navigate life after childhood cancer.

At #SIOP2026, Alyaa Al-Ibraheemi, MD, explores the molecular landscape of rare, aggressive rhabdomyosarcoma — and how a deeper understanding of tumor biology may help sharpen diagnosis and inform new therapeutic approaches.

“Experience matters when thinking about a good outcome. It’s not just the surgeon, it’s the whole team,” Davidoff said. #SIOPcongress #SIOP2026

St. Jude experts, Global Scholars, trainees and collaborators are heading to #SIOP2026 in San Antonio next week.